116 related articles for article (PubMed ID: 9389547)
1. Two distinct pituitary cell lines from mouse intermediate lobe tumors: a cell that produces prolactin-regulating factor and a melanotroph [seecomments].
Hnasko R; Khurana S; Shackleford N; Steinmetz R; Low MJ; Ben-Jonathan N
Endocrinology; 1997 Dec; 138(12):5589-96. PubMed ID: 9389547
[TBL] [Abstract][Full Text] [Related]
2. Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.
Hnasko R; Ben-Jonathan N
Endocrine; 2003; 20(1-2):35-44. PubMed ID: 12668866
[TBL] [Abstract][Full Text] [Related]
3. Identification of two classes of prolactin-releasing factors in intermediate lobe tumors from transgenic mice.
Allen DL; Low MJ; Allen RG; Ben-Jonathan N
Endocrinology; 1995 Jul; 136(7):3093-9. PubMed ID: 7789336
[TBL] [Abstract][Full Text] [Related]
4. Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene.
Low MJ; Liu B; Hammer GD; Rubinstein M; Allen RG
J Biol Chem; 1993 Nov; 268(33):24967-75. PubMed ID: 8227058
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-releasing factor: cellular origin in the intermediate lobe of the pituitary.
Laudon M; Grossman DA; Ben-Jonathan N
Endocrinology; 1990 Jun; 126(6):3185-92. PubMed ID: 2112457
[TBL] [Abstract][Full Text] [Related]
6. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
7. Coculturing posterior pituitary and GH3 cells: dramatic stimulation of prolactin gene expression.
Corcia A; Steinmetz R; Liu JW; Ben-Jonathan N
Endocrinology; 1993 Jan; 132(1):80-5. PubMed ID: 8419149
[TBL] [Abstract][Full Text] [Related]
8. The rat posterior pituitary contains a potent prolactin-releasing factor: studies with perifused anterior pituitary cells.
Hyde JF; Murai I; Ben-Jonathan N
Endocrinology; 1987 Oct; 121(4):1531-9. PubMed ID: 2888647
[TBL] [Abstract][Full Text] [Related]
9. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary.
Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK
Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526
[TBL] [Abstract][Full Text] [Related]
10. Target cells of gamma3-melanocyte-stimulating hormone detected through intracellular Ca2+ responses in immature rat pituitary constitute a fraction of all main pituitary cell types, but mostly express multiple hormone phenotypes at the messenger ribonucleic acid level. Refractoriness to melanocortin-3 receptor blockade in the lacto-somatotroph lineage.
Roudbaraki M; Lorsignol A; Langouche L; Callewaert G; Vankelecom H; Denef C
Endocrinology; 1999 Oct; 140(10):4874-85. PubMed ID: 10499547
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta and p27 expression in pituitary cells.
Qian X; Jin L; Grande JP; Lloyd RV
Endocrinology; 1996 Jul; 137(7):3051-60. PubMed ID: 8770931
[TBL] [Abstract][Full Text] [Related]
12. Activation of the prolactin promoter in transfected GH3 cells by posterior pituitary cells.
Steinmetz R; Gutierrez-Hartmann A; Bigsby RM; Ben-Jonathan N
Endocrinology; 1994 Dec; 135(6):2737-41. PubMed ID: 7988465
[TBL] [Abstract][Full Text] [Related]
13. Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene.
Stefaneanu L; Rindi G; Horvath E; Murphy D; Polak JM; Kovacs K
Endocrinology; 1992 Apr; 130(4):1789-95. PubMed ID: 1312426
[TBL] [Abstract][Full Text] [Related]
14. MtTW-10 pituitary tumor cells: galanin gene expression and peptide secretion.
Hyde JF; Morrison DG; Moore JP; Howard G
Endocrinology; 1993 Dec; 133(6):2588-93. PubMed ID: 7694842
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.
Shimon I; Hüttner A; Said J; Spirina OM; Melmed S
J Clin Invest; 1996 Jan; 97(1):187-95. PubMed ID: 8550832
[TBL] [Abstract][Full Text] [Related]
16. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
Seo H; Refetoff S; Fang VS
Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
[TBL] [Abstract][Full Text] [Related]
17. Specific repression of rat prolactin gene expression in transplanted tumor cells.
Day RN; Day KH
Mol Endocrinol; 1994 Jan; 8(1):12-20. PubMed ID: 8152427
[TBL] [Abstract][Full Text] [Related]
18. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
Trouillas J; Chevallier P; Remy C; Rajas F; Cohen R; Calle A; Hooghe-Peters EL; Rousset B
Endocrinology; 1999 Jan; 140(1):13-21. PubMed ID: 9886801
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.
Zafar M; Ezzat S; Ramyar L; Pan N; Smyth HS; Asa SL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3621-7. PubMed ID: 8530610
[TBL] [Abstract][Full Text] [Related]
20. Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice.
Zhou Z; Flesken-Nikitin A; Levine CG; Shmidt EN; Eng JP; Nikitina EY; Spencer DM; Nikitin AY
Cancer Res; 2005 Feb; 65(3):787-96. PubMed ID: 15705875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
